Pharmaceutical Industry Information Portal

HomePharmaceutical Investing News

Pharmaceutical Investing News

Bristol Myers Squibb announces a $4.1 billion deal to acquire Turning Point Therapeutics

Pharmaceutical giant Bristol Myers Squibb Company announced a $4.1 billion deal for Turning Point Therapeutics Inc  on Friday morning, the first sizable acquisition for...

LUCA Science Raises $30.3 Million to accelerate development novel MIT platform

Luca Science is a private biotechnology company headquartered in Japan, a global innovator in the development of a novel class of mitochondria biopharmaceutical agents,...

Upstream Bio raises $200 million to develop treatment for severe asthma

Upstream Bio, a biotech company focused on inflammation, debuted with a $200 million Series A financing. The funding will allow Upstream to advance the...

Moderna’s delivery of COVID-19 booster doses to EU is postponed, shares drop

Shares of Moderna are trading 2% lower Thursday morning as the company announced it had agreed to amend the delivery schedule of additional COVID-19...

Pfizer sells its stake in Haleon, GSK’s consumer healthcare division

Pfizer will sell down its stake in Haleon, the consumer healthcare unit of GSK, after its listing in London planned for later this month,...

Evonik invests $220 million to build mRNA lipid production facility in the U.S.

Evonik, one of the world's leading providers of drug delivery technologies, is building a new, highly flexible, global-scale production facility for pharmaceutical lipids in...
spot_img

Expert Articles

spot_img